Log in
Enquire now
‌

US Patent 10344033 2-aminoquinazoline derivatives as P70S6 kinase inhibitors

Patent 10344033 was granted and assigned to Sentinel Oncology Limited on July, 2019 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent

Patent attributes

Patent Applicant
‌
Sentinel Oncology Limited
Current Assignee
‌
Sentinel Oncology Limited
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
10344033
Patent Inventor Names
Robert George Boyle0
David Winter Walker0
Date of Patent
July 9, 2019
Patent Application Number
15764960
Date Filed
September 30, 2016
Patent Citations Received
‌
US Patent 10730882 2-aminoquinazoline derivatives as P70S6 kinase inhibitors
Patent Primary Examiner
‌
Golam M. Shameem
Patent abstract

The invention provides compound that inhibit or modulate the activity of p70S6 kinase, the compounds being of the formula (1):

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 10344033 2-aminoquinazoline derivatives as P70S6 kinase inhibitors

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.